The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

9 Jul 2020 10:00

RNS Number : 5429S
Maven Income and Growth VCT 3 PLC
09 July 2020
 

Maven Income and Growth VCT 3 PLC (the Company)

 

Issue of Equity

 

 

 

On 13 November 2019, the Company and Maven Income and Growth VCT 4 PLC launched a joint offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £7.5 million (the Offer). On 28 January 2020, the Board announced that it had received subscriptions up to its fundraising limit of £7.5 million and that the Offer was closed for further applications.

 

Pursuant to the Offer, and the £798,290 of valid applications received in respect of the 2020/2021 tax year, the Company has issued and allotted 1,443,232 new Ordinary Shares on 9 July 2020. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 55.29p to 55.45p per Ordinary Share.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 13 July 2020.

 

Following this final allotment, a total of 12,508,804 Ordinary Shares have been issued by the Company pursuant to the Offer, and the number of Ordinary Shares now in issue is 79,780,710. Therefore, the total number of voting rights in the Company is 79,780,710.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

9 July 2020

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFIFFTDTIAIII
Date   Source Headline
17th Oct 20082:14 pmRNSInterim Management Statement
16th Oct 20082:54 pmRNSResult of EGM
29th Aug 200811:17 amRNSCirc re GM, and issue of inte
16th Jul 20084:34 pmRNSDirectorate Change
15th Jul 20084:17 pmRNSInterim Results
25th Apr 20083:24 pmRNSResult of AGM
17th Apr 200810:23 amRNSInterim Management Statement
7th Mar 20084:01 pmRNSAnnual Information Update
29th Feb 20084:23 pmRNSAnnual Report and Accounts
6th Feb 200811:51 amRNSFinal Results
20th Jul 20075:05 pmRNSInterim Results
12th Jun 20073:14 pmRNSAnnual Information Update
7th Jun 200712:47 pmRNSResult of AGM
7th Feb 20075:13 pmRNSFinal Results
20th Dec 20064:52 pmRNSTotal Voting Rights
8th Nov 20063:08 pmRNSNet Asset Value(s)
14th Jul 20065:11 pmRNSInterim Results
29th Jun 200610:51 amRNSDirector/PDMR Shareholding
29th Jun 200610:50 amRNSDirector/PDMR Shareholding
29th Jun 200610:40 amRNSDirector/PDMR Shareholding
24th May 20069:31 amRNSTransaction in Own Shares
28th Apr 200610:21 amRNSResult of AGM
21st Apr 200611:12 amRNSTransaction in Own Shares
6th Apr 200610:17 amRNSIssue of Equity
4th Apr 200612:10 pmRNSIssue of Equity
3rd Apr 20064:41 pmRNSDoc re.Offer for Subscription
14th Mar 20069:44 amRNSDividend Declaration
21st Feb 20062:48 pmRNSAnnual Information Update
15th Feb 20064:10 pmRNSIssue of Equity
27th Jan 200610:20 amRNSDoc re. Prospectus
24th Jan 200610:36 amRNSAnnual Report and Accounts
30th Dec 20059:57 amRNSFinal Results
22nd Dec 200511:04 amRNSResult of EGM
1st Dec 20055:00 pmRNSStatement re Portfolio Update
29th Nov 20053:10 pmRNSTransaction in Own Shares
18th Nov 20054:57 pmRNSCirc re C Shares
1st Nov 20053:55 pmRNSDirectorate Change
25th Oct 20054:50 pmRNSTransaction in Own Shares
14th Oct 20054:50 pmRNSTransaction in Own Shares
29th Jul 20053:41 pmRNSTransaction in Own Shares
25th Jul 20052:32 pmRNSInterim Results
31st May 20054:21 pmRNSInvestment Activity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.